Inactive Instrument

Company Lannett Company, Inc. Nyse MKT

Equities

LCI

US5160121019

Pharmaceuticals

Business Summary

Lannett Company, Inc. is engaged in the development, manufacturing, marketing and distribution of generic versions of brand pharmaceutical products. The Company markets approximately 100 products, mainly tablet, capsule or liquid oral generic medications. Its marketed products include generics such as Posaconazole, Fluphenazine, Levothyroxine, Sumatriptan and NDA-based product Numbrino. The Company's product portfolio include Amphetamine IR Tablets, which are used to treat Attention deficit hyperactivity disorder (ADHD) and narcolepsy; Dicyclomine tablets, used for the treatment of functional bowel disorder and irritable bowel syndrome; Levothyroxine Capsules, used to treat patients with hypothyroidism and other conditions, and Numbrino Nasal Solution, used for the induction of local anesthesia of the mucous membranes when performing diagnostic procedures and surgeries on or through the nasal cavities in adults, among others.

Managers

Managers TitleAgeSince
Chief Executive Officer 63 18-01-01
Chief Tech/Sci/R&D Officer - 98-12-31
Corporate Officer/Principal - 11-12-31
Corporate Officer/Principal 65 18-05-06
Corporate Officer/Principal - 18-01-31
General Counsel 63 17-07-16
Corporate Officer/Principal 59 15-03-29

Members of the board

Members of the board TitleAgeSince
Director/Board Member - -
Chairman - 23-06-15
Director/Board Member 50 23-06-15
Chief Executive Officer 63 18-01-01
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,218,128 9,231,253 ( 82.29 %) 437,941 ( 3.904 %) 82.29 %

Company contact information

Lannett Co., Inc.

1150 Northbrook Drive Suite 155

19053, Trevose

+215 333 9000

http://www.lannett.com
address Lannett Company, Inc.(LCI)